난소암 시장 규모는 향후 몇 년 동안 기하급수적인 성장을 보일 것으로 예상됩니다. 예측 기간의 성장은 표적 치료 및 개인 맞춤 의학에 대한 연구 증가, 노인 인구 증가, 의료 인식 증가, 난소암 유병률 증가, 의료비 지출 증가에 기인할 수 있습니다. 예측 기간의 주요 트렌드에는 혁신적인 치료법, 방사선 치료의 발전, 향상된 의료 인프라, 기술 발전 및 신약 채택이 포함됩니다.
여성 인구의 증가는 난소암 시장의 확장을 주도할 것으로 예상됩니다. 여성 인구는 특정 지역 또는 특정 시점에 전 세계에 거주하는 여성의 총 수를 의미합니다. 이러한 증가는 기대 수명 증가, 의료 서비스 개선, 인구 통계학적 변화와 같은 요인에 의해 영향을 받습니다. 수술, 화학 치료, 표적 치료, 면역 치료을 포함한 난소암 치료는 암세포를 제거하고 질병 진행을 늦추며 증상을 완화하고 생존율을 개선함으로써 여성 인구를 지원합니다. 이러한 치료법은 궁극적으로 삶의 질을 향상시키고 장기적으로 더 나은 결과를 기대할 수 있게 해줍니다. 예를 들어, 미국 정부 기관인 인구조사국에 따르면 2022년 7월 현재 미국의 여성 인구는 85세 이상 여성 약 190만 명을 포함하여 약 1억 6,800만 명으로 추산됩니다. 또한, 영국에 본사를 둔 금융 서비스 회사인 CEIC Data가 2022년 12월에 발표한 보고서에 따르면, 15-64세의 여성 인구는 2021년의 294만 645명으로부터 증가하여 2022년에는 295만 1,856명에 달했습니다. 결과적으로 여성 인구의 증가는 난소암 시장의 성장에 기여하고 있습니다.
난소암 시장의 기업들은 복잡한 의료 데이터 분석의 정확성을 높이기 위해 AI 플랫폼과 같은 첨단 솔루션을 우선적으로 도입하고 있습니다. 난소암 AI 플랫폼은 인공지능(AI)과 머신러닝(ML)을 활용하여 난소암 치료의 다양한 측면을 개선하는 기술 중심 시스템입니다. 이 플랫폼은 의료 영상, 게놈 데이터, 전자 건강 기록(EHR), 실시간 분석을 통합하여 조기 발견, 진단, 개인 맞춤형 치료 계획, 환자 모니터링을 지원합니다. 예를 들어, 2024년 2월 AIIMS 델리는 인도에 본사를 둔 기관인 CDAC 푸네와 협력하여 유방암과 난소암의 조기 발견을 위한 AI 기반 플랫폼인 iOncology.ai를 출시했습니다. 이 플랫폼은 딥러닝 모델을 사용하여 방사선 및 조직 병리학적 이미지를 높은 정확도로 분석하여 조기 진단과 생존율 향상을 목표로 합니다. 이미 여러 병원에서 구현된 iOncology.ai는 의료 시스템과 통합되어 위험 평가를 제공하고 유방 촬영을 추천하며, 특히 농촌 지역의 여성에게 혜택을 제공합니다. 이는 AI를 의료 분야에 통합하고 의료 시설의 부담을 완화하기 위한 광범위한 노력의 일환입니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 - 거시경제 시나리오 금리, 인플레이션, 지정학, 신형 코로나 바이러스 감염의 영향과 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
- 세계의 난소암 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
- 최종 이용 산업의 분석
- 세계의 난소암 시장 : 성장률 분석
- 세계의 난소암 시장 실적 : 규모와 성장(2019-2024년)
- 세계의 난소암 시장 예측 : 규모와 성장(2024-2029년, 2034년)
- 세계의 난소암 총 시장 규모(TAM)
제6장 시장 세분화
- 세계의 난소암 시장 : 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
- 상피성 난소 종양
- 난소 생식 세포 종양
- 난소 간질 종양
- 원발성 복막암
- 세계의 난소암 시장 : 치료별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
- 화학 치료
- 표적 치료
- 방사선 치료
- 면역 치료
- 호르몬 치료
- 수술
- 세계의 난소암 시장 : 투여 경로별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
- 경구
- 비경구
- 기타 투여 경로
- 세계의 난소암 시장 : 최종 사용자별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
- 병원
- 진단센터
- 약국
- 온라인 약국
- 기타 최종 사용자
- 세계의 난소암 시장 : 상피성 난소 종양 유형별 세분화, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
- 장액성 암
- 점액성 암
- 자궁내막암
- 명세포암
- 브레너 종양
- 세계의 난소암 시장 : 난소 생식 세포 종양 유형별 세분화, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
- 이상 생식 종
- 기형종
- 난황낭종양
- 배아 암
- 융모막암
- 세계의 난소암 시장 : 난소 간질 종양 유형별 세분화, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
- 과립구 세포 종양
- 테코 매스
- 세르톨리-레이디그 세포 종양
- 세계의 난소암 시장 : 원발성 복막암 유형별 세분화, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
- 고악성 장액성 암
- 저악성 장액성 암
제7장 지역별 및 국가별 분석
- 세계의 난소암 시장 : 지역별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
- 세계의 난소암 시장 : 국가별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 프로파일
- 난소암 시장 : 경쟁 구도
- 난소암 시장 : 기업 프로파일
- Pfizer Incorporated 개요, 제품 및 서비스, 전략 및 재무 분석
- Johnson & Johnson Services Inc. 개요, 제품 및 서비스, 전략 및 재무 분석
- Roche Holding AG 개요, 제품 및 서비스, 전략 및 재무 분석
- Merck & Co. Inc. 개요, 제품 및 서비스, 전략 및 재무 분석
- AbbVie Inc. 개요, 제품 및 서비스, 전략 및 재무 분석
제31장 기타 주요 기업 및 혁신 기업
- Bayer Aktiengesellschaft
- Sanofi SA
- AstraZeneca PLC
- Abbott Laboratories
- GlaxoSmithKline plc
- Eli Lilly and Company
- Boehringer Ingelheim GmbH
- Bausch Health Companies Inc.
- Bristol-Myers Squibb Company
- Sun Pharmaceutical Industries Limited
- Cipla Limited
- Hikma Pharmaceuticals PLC
- Lupin Limited
- Novogen Limited
- Oasmia Pharmaceutical AB
제32장 세계 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문, 전략
- 난소암 시장(2029년) : 새로운 기회를 제공하는 국가
- 난소암 시장(2029년) : 새로운 기회를 제공하는 부문
- 난소암 시장(2029년) : 성장 전략
제36장 부록
HBR
Ovarian cancer is a type of cancer that begins in the ovaries, the female reproductive organs responsible for producing eggs (ova) and hormones such as estrogen and progesterone. It can originate in different parts of the ovaries, including the surface epithelium, germ cells, or stroma.
The primary types of ovarian cancer include epithelial ovarian tumors, ovarian germ cell tumors, ovarian stromal tumors, and primary peritoneal carcinoma. Epithelial ovarian tumors arise from the epithelial cells that form the outer lining of the ovaries. Treatment options include chemotherapy, targeted therapy, radiation therapy, immunotherapy, hormonal therapy, and surgery. These treatments are administered through various routes, such as oral, parenteral, and other methods, and are utilized by different end-users, including hospitals, diagnostic centers, drug stores, online pharmacies, and others.
The ovarian cancer market research report is one of a series of new reports from The Business Research Company that provides ovarian cancer market statistics, including the ovarian cancer industry global market size, regional shares, competitors with the ovarian cancer market share, detailed ovarian cancer market segments, market trends, and opportunities, and any further data you may need to thrive in the ovarian cancer industry. This ovarian cancer market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The ovarian cancer market size has grown exponentially in recent years. It will grow from $3.67 billion in 2024 to $4.36 billion in 2025 at a compound annual growth rate (CAGR) of 18.9%. The growth during the historic period can be attributed to the rising elderly population, the increasing incidence of ovarian cancer cases, the growing prevalence of ovarian cancer, the expansion of government initiatives, and the rise in healthcare spending.
The ovarian cancer market size is expected to see exponential growth in the next few years. It will grow to $8.61 billion in 2029 at a compound annual growth rate (CAGR) of 18.5%. The growth in the forecast period can be attributed to increased research on targeted therapies and personalized medicine, a growing geriatric population, rising healthcare awareness, the increasing prevalence of ovarian cancer, and rising healthcare expenditures. Major trends in the forecast period include innovative therapies, advancements in radiation therapy, enhanced healthcare infrastructure, technological advancements, and the adoption of novel drugs.
The growing female population is anticipated to drive the expansion of the ovarian cancer market. The female population refers to the total number of females residing in a specific region or worldwide at a given time. This increase is influenced by factors such as higher life expectancy, improved healthcare, and demographic changes. Ovarian cancer treatments, including surgery, chemotherapy, targeted therapy, and immunotherapy, support the female population by removing cancerous cells, slowing disease progression, alleviating symptoms, and improving survival rates. These treatments ultimately enhance quality of life and provide hope for better long-term outcomes. For example, according to the Census Bureau, a US-based government agency, as of July 2022, the United States had an estimated female population of approximately 168 million, including about 1.9 million females aged 85 and older. Furthermore, a report published in December 2022 by CEIC Data, a UK-based financial services company, indicated that the number of females aged 15-64 reached 2,951,856 in 2022, up from 2,940,645 in 2021. As a result, the rising female population is contributing to the growth of the ovarian cancer market.
Companies in the ovarian cancer market are prioritizing advanced solutions, such as AI platforms, to enhance the accuracy of complex medical data analysis. An AI platform for ovarian cancer is a technology-driven system that utilizes artificial intelligence (AI) and machine learning (ML) to improve various aspects of ovarian cancer care. These platforms integrate medical imaging, genomic data, electronic health records (EHRs), and real-time analytics to support early detection, diagnosis, personalized treatment planning, and patient monitoring. For example, in February 2024, AIIMS Delhi, in collaboration with CDAC Pune, an India-based organization, introduced iOncology.ai, an AI-powered platform for the early detection of breast and ovarian cancer. This platform employs deep learning models to analyze radiological and histopathological images with high accuracy, aiming to improve early diagnosis and survival rates. Already implemented in multiple hospitals, iOncology.ai integrates with the healthcare system to provide risk assessments and recommend mammograms, particularly benefiting women in rural areas. This initiative is part of a broader effort to incorporate AI into healthcare and alleviate pressure on medical facilities.
In February 2024, AbbVie Inc., a US-based biopharmaceutical company, acquired ImmunoGen Inc. for an undisclosed amount. The acquisition aimed to enhance AbbVie's oncology portfolio by incorporating ImmunoGen's innovative antibody-drug conjugate, ELAHERE, alongside other promising cancer therapies. ImmunoGen Inc. is a US-based biotechnology company specializing in the development of antibody-drug conjugates (ADCs) for the treatment of ovarian cancer.
Major players in the ovarian cancer market are Pfizer Incorporated, Johnson & Johnson Services Inc., Roche Holding AG, Merck & Co. Inc., AbbVie Inc., Bayer Aktiengesellschaft, Sanofi S.A., AstraZeneca PLC, Abbott Laboratories, GlaxoSmithKline plc, Eli Lilly and Company, Boehringer Ingelheim GmbH, Bausch Health Companies Inc., Bristol-Myers Squibb Company, Sun Pharmaceutical Industries Limited, Cipla Limited, Hikma Pharmaceuticals PLC, Lupin Limited, Novogen Limited, Oasmia Pharmaceutical AB, Clovis Oncology Inc., Aeterna Zentaris Inc., Allarity Therapeutics Inc., Ellipses Pharma Ltd.
North America was the largest region in the ovarian cancer market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in ovarian cancer report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the ovarian cancer market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The ovarian cancer market consists of revenues earned by entities by providing services such as screening and early detection services, diagnostic imaging services, surgical treatment services, clinical trial services, and palliative and supportive care services. The market value includes the value of related goods sold by the service provider or included within the service offering. The ovarian cancer market also includes sales of taxane-based chemotherapy, surgical treatment devices, radiation therapy equipment, angiogenesis inhibitors, and checkpoint inhibitors. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Ovarian Cancer Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on ovarian cancer market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for ovarian cancer ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The ovarian cancer market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
- Markets Covered:1) By Type: Epithelial Ovarian Tumors; Ovarian Germ Cell Tumors; Ovarian Stromal Tumors; Primary Peritoneal Carcinoma
- 2) By Treatment: Chemotherapy; Targeted Therapy; Radiation Therapy; Immunotherapy; Hormonal Therapy; Surgery
- 3) By Route Of Administration: Oral; Parenteral; Other Route Of Administrations
- 4) By End-user: Hospitals; Diagnostic Centers; Drug Stores; Online Pharmacies; Other End Users
- Subsegments:
- 1) By Epithelial Ovarian Tumors: Serous Carcinoma; Mucinous Carcinoma; Endometrioid Carcinoma; Clear Cell Carcinoma; Brenner Tumors
- 2) By Ovarian Germ Cell Tumors: Dysgerminoma; Teratoma; Yolk Sac Tumor; Embryonal Carcinoma; Choriocarcinoma
- 3) By Ovarian Stromal Tumors: Granulosa Cell Tumors; Thecomas; Sertoli-Leydig Cell Tumors
- 4) By Primary Peritoneal Carcinoma: High-Grade Serous Carcinoma; Low-Grade Serous Carcinoma
- Companies Mentioned: Pfizer Incorporated; Johnson & Johnson Services Inc.; Roche Holding AG; Merck & Co. Inc.; AbbVie Inc.
- Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
- Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
- Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- Delivery format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Ovarian Cancer Market Characteristics
3. Ovarian Cancer Market Trends And Strategies
4. Ovarian Cancer Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market
5. Global Ovarian Cancer Growth Analysis And Strategic Analysis Framework
- 5.1. Global Ovarian Cancer PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Ovarian Cancer Market Growth Rate Analysis
- 5.4. Global Ovarian Cancer Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Ovarian Cancer Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Ovarian Cancer Total Addressable Market (TAM)
6. Ovarian Cancer Market Segmentation
- 6.1. Global Ovarian Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Epithelial Ovarian Tumors
- Ovarian Germ Cell Tumors
- Ovarian Stromal Tumors
- Primary Peritoneal Carcinoma
- 6.2. Global Ovarian Cancer Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Chemotherapy
- Targeted Therapy
- Radiation Therapy
- Immunotherapy
- Hormonal Therapy
- Surgery
- 6.3. Global Ovarian Cancer Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Oral
- Parenteral
- Other Route Of Administrations
- 6.4. Global Ovarian Cancer Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hospitals
- Diagnostic Centers
- Drug Stores
- Online Pharmacies
- Other End Users
- 6.5. Global Ovarian Cancer Market, Sub-Segmentation Of Epithelial Ovarian Tumors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Serous Carcinoma
- Mucinous Carcinoma
- Endometrioid Carcinoma
- Clear Cell Carcinoma
- Brenner Tumors
- 6.6. Global Ovarian Cancer Market, Sub-Segmentation Of Ovarian Germ Cell Tumors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Dysgerminoma
- Teratoma
- Yolk Sac Tumor
- Embryonal Carcinoma
- Choriocarcinoma
- 6.7. Global Ovarian Cancer Market, Sub-Segmentation Of Ovarian Stromal Tumors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Granulosa Cell Tumors
- Thecomas
- Sertoli-Leydig Cell Tumors
- 6.8. Global Ovarian Cancer Market, Sub-Segmentation Of Primary Peritoneal Carcinoma, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- High-Grade Serous Carcinoma
- Low-Grade Serous Carcinoma
7. Ovarian Cancer Market Regional And Country Analysis
- 7.1. Global Ovarian Cancer Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Ovarian Cancer Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Ovarian Cancer Market
- 8.1. Asia-Pacific Ovarian Cancer Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Ovarian Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Ovarian Cancer Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Ovarian Cancer Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Ovarian Cancer Market
- 9.1. China Ovarian Cancer Market Overview
- 9.2. China Ovarian Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Ovarian Cancer Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Ovarian Cancer Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Ovarian Cancer Market
- 10.1. India Ovarian Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Ovarian Cancer Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Ovarian Cancer Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Ovarian Cancer Market
- 11.1. Japan Ovarian Cancer Market Overview
- 11.2. Japan Ovarian Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Ovarian Cancer Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Ovarian Cancer Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Ovarian Cancer Market
- 12.1. Australia Ovarian Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Ovarian Cancer Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Ovarian Cancer Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Ovarian Cancer Market
- 13.1. Indonesia Ovarian Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Ovarian Cancer Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Ovarian Cancer Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Ovarian Cancer Market
- 14.1. South Korea Ovarian Cancer Market Overview
- 14.2. South Korea Ovarian Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Ovarian Cancer Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Ovarian Cancer Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Ovarian Cancer Market
- 15.1. Western Europe Ovarian Cancer Market Overview
- 15.2. Western Europe Ovarian Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Ovarian Cancer Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Ovarian Cancer Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Ovarian Cancer Market
- 16.1. UK Ovarian Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Ovarian Cancer Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Ovarian Cancer Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Ovarian Cancer Market
- 17.1. Germany Ovarian Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Ovarian Cancer Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Ovarian Cancer Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Ovarian Cancer Market
- 18.1. France Ovarian Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Ovarian Cancer Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Ovarian Cancer Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Ovarian Cancer Market
- 19.1. Italy Ovarian Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Ovarian Cancer Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Ovarian Cancer Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Ovarian Cancer Market
- 20.1. Spain Ovarian Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Ovarian Cancer Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Ovarian Cancer Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Ovarian Cancer Market
- 21.1. Eastern Europe Ovarian Cancer Market Overview
- 21.2. Eastern Europe Ovarian Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Ovarian Cancer Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Ovarian Cancer Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Ovarian Cancer Market
- 22.1. Russia Ovarian Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Ovarian Cancer Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Ovarian Cancer Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Ovarian Cancer Market
- 23.1. North America Ovarian Cancer Market Overview
- 23.2. North America Ovarian Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Ovarian Cancer Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Ovarian Cancer Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Ovarian Cancer Market
- 24.1. USA Ovarian Cancer Market Overview
- 24.2. USA Ovarian Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Ovarian Cancer Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Ovarian Cancer Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Ovarian Cancer Market
- 25.1. Canada Ovarian Cancer Market Overview
- 25.2. Canada Ovarian Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Ovarian Cancer Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Ovarian Cancer Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Ovarian Cancer Market
- 26.1. South America Ovarian Cancer Market Overview
- 26.2. South America Ovarian Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Ovarian Cancer Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Ovarian Cancer Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Ovarian Cancer Market
- 27.1. Brazil Ovarian Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Ovarian Cancer Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Ovarian Cancer Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Ovarian Cancer Market
- 28.1. Middle East Ovarian Cancer Market Overview
- 28.2. Middle East Ovarian Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Ovarian Cancer Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Ovarian Cancer Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Ovarian Cancer Market
- 29.1. Africa Ovarian Cancer Market Overview
- 29.2. Africa Ovarian Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Ovarian Cancer Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Ovarian Cancer Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Ovarian Cancer Market Competitive Landscape And Company Profiles
- 30.1. Ovarian Cancer Market Competitive Landscape
- 30.2. Ovarian Cancer Market Company Profiles
- 30.2.1. Pfizer Incorporated Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Johnson & Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
31. Ovarian Cancer Market Other Major And Innovative Companies
- 31.1. Bayer Aktiengesellschaft
- 31.2. Sanofi S.A.
- 31.3. AstraZeneca PLC
- 31.4. Abbott Laboratories
- 31.5. GlaxoSmithKline plc
- 31.6. Eli Lilly and Company
- 31.7. Boehringer Ingelheim GmbH
- 31.8. Bausch Health Companies Inc.
- 31.9. Bristol-Myers Squibb Company
- 31.10. Sun Pharmaceutical Industries Limited
- 31.11. Cipla Limited
- 31.12. Hikma Pharmaceuticals PLC
- 31.13. Lupin Limited
- 31.14. Novogen Limited
- 31.15. Oasmia Pharmaceutical AB
32. Global Ovarian Cancer Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Ovarian Cancer Market
34. Recent Developments In The Ovarian Cancer Market
35. Ovarian Cancer Market High Potential Countries, Segments and Strategies
- 35.1 Ovarian Cancer Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Ovarian Cancer Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Ovarian Cancer Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
